McKesson Agrees to $141 Million Payout Related to Generic Drug Pricing Conspiracy
McKesson Corp. has reached a tentative $141 million settlement resolving allegations it misled investors about profits from a price-fixing conspiracy amongst generic drug manufacturers. The